ModelEdge

Trillium Therapeutics Inc.
0001616212
Filing Type8-K
Filing Date11/16/2021
Updated11/17/21, 2:28 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events
EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events
GRAPHICGraphic